# OnCo record sandoz (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/sandoz/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "sandoz" ;
  schema:name "Sandoz"@en ;
  schema:description "Sandoz, spun out of Novartis in 2023, is the world's largest generics and biosimilars company; in oncology it sells biosimilar filgrastim (Zarxio), pegfilgrastim (Ziextenzo) and rituximab, and holds the US application for nelarabine (Arranon)."@en ;
  schema:url <https://onco.cc/companies/sandoz/>, <https://www.sandoz.com> ;
  schema:dateModified "2026-09-10"^^xsd:date ;
  schema:citation <https://www.sandoz.com> ;
  schema:addressCountry "CH" .